Kadıoğlu Nezaket, Güler Başak, Özler Sibel, Kılıç Sevtap, Çiçek M Nedim, Batıoğlu A Sertaç
Department of Obstetrics and Gynecology, Şereflikoçhisar Government Hospital, Ankara, Turkey.
Department of Obstetrics and Gynecology, Liv Hospital, Ankara, Turkey.
Adv Ther. 2016 Aug;33(8):1408-16. doi: 10.1007/s12325-016-0356-z. Epub 2016 Jun 21.
Our aim in this study is to evaluate the effects of in vitro fertilization (IVF), including controlled ovarian hyperstimulation (COH) and the number of oocyte pick-up (OPU) procedures on the development of anti-ovarian antibodies (AOA).
To evaluate the effects of IVF procedures, namely, COH and OPU, serum samples for measuring AOA concentration levels by enzyme-linked immunosorbent assay were collected on the third day of the menstrual cycle, at the end of the COH, and after OPU.
The AOA levels in IVF patients were significantly higher than the fertile control groups'. In the IVF group, neither COH nor OPU caused any increase in AOA levels when compared to the basal results. AOA levels were higher in patients with a history of 5-8 cycles of ovulation induction, before IVF treatment. There was no relationship between the basal AOA concentrations and the type of infertility, the etiology of infertility or the pregnancy outcomes, whereas there was a relationship between the AOA and the duration of infertility.
AOA levels of IVF patients were found to be higher than the fertile control groups'. AOA was found to be related to infertility in patients who had a longer duration of infertility and repeated ovulation induction procedures without IVF. COH and OPU during an IVF cycle did not cause an increase in AOA levels.
本研究的目的是评估体外受精(IVF),包括控制性卵巢刺激(COH)和取卵(OPU)程序的次数对抗卵巢抗体(AOA)产生的影响。
为评估IVF程序(即COH和OPU)的影响,在月经周期的第三天、COH结束时以及OPU后,采集用于通过酶联免疫吸附测定法测量AOA浓度水平的血清样本。
IVF患者的AOA水平显著高于可育对照组。在IVF组中,与基础结果相比,COH和OPU均未导致AOA水平升高。在IVF治疗前,有5 - 8个排卵诱导周期病史的患者AOA水平更高。基础AOA浓度与不孕类型、不孕病因或妊娠结局之间没有关系,而AOA与不孕持续时间之间存在关系。
发现IVF患者的AOA水平高于可育对照组。发现AOA与不孕持续时间较长且在未进行IVF的情况下反复进行排卵诱导程序的患者的不孕有关。IVF周期中的COH和OPU不会导致AOA水平升高。